Announcing the first publication for our ResistancePlus™ MG assay, published in PLOS ONE in collaboration with Sepehr Tabrizi, PhD at the Royal Women’s Hospital in Melbourne, Australia.
“The SpeeDx assay provides valuable information to the clinicians in a rapid timeframe allowing for better treatment of patients infected with M. genitalium,” says Dr. Tabrizi. “We believe this study is a positive first step in combatting the growing problem of antibiotic resistance in M. genitalium.”
read the press release here
read the PLOS ONE article here